True Nature (TNTY) Stock Price, News & Analysis

Company Overview

True Nature Holding, Inc. focuses on engaging in compounding pharmacy activities direct to consumers, doctors, and veterinary professionals. It also focuses on the development of software applications in the healthcare arena, including telemedicine; and consideration of services offering using blockchain encryption technology for various aspects of the healthcare industry. The company is based in Atlanta, Georgia.

Key Stats

• Today's Range: $0.27 to $0.44
• 50-Day Range: $0.32 to $0.62
• 52-Week Range: $0.02 to $0.11
• Volume: 341 shs
• Average Volume: 785,609 shs
• Market Capitalization: $34.45 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

TNTY Stock Analysis - Frequently Asked Questions

How have TNTY shares performed this year?

True Nature's stock was trading at $0.46 on January 1st, 2025. Since then, TNTY shares have decreased by 13.5% and is now trading at $0.3980.
View the best growth stocks for 2025 here.

How do I buy shares of True Nature?

Shares of TNTY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of True Nature own?

Based on aggregate information from My MarketBeat watchlists, some other companies that True Nature investors own include Advanced Micro Devices (AMD), Alibaba Group (BABA), Brookline Capital Acquisition (BCAC), Banxa (BNXAF), Crane (CR), Ford Motor (F) and GS Acquisition Holdings Corp II (GSAH).

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Computer and Technology
• Industry: Communication Equipment
• Sub-Industry: Healthcare
• Current Symbol: OTCMKTS:TNTY
• CIK: 802257
• Web: truenatureholding.com
• Phone: 844-383-8689
• Fax: N/A
• Employees: 30
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $-3,880,000.00
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: -13,987.90%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 0.04
• Quick Ratio: 0.04

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: ($0.03) per share
• Price / Book: -13.27

Miscellaneous

• Outstanding Shares: 86,567,000
• Free Float: N/A
• Market Cap: $34.45 million
• Optionable: Not Optionable
• Beta: 2.99